Fine SpikeToday's spike led us back into the trading range that had prevailed since September. It may be a sign of a bottom at the end of December.
Key facts today
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.1869 USD
−54.05 M USD
4.05 M USD
286.77 M
About Ocugen, Inc.
Sector
Industry
CEO
Shankar Musunuri
Website
Headquarters
Malvern
Founded
2013
FIGI
BBG00194VJB1
Ocugen, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies to cure eye diseases. Its product pipeline candidates include OCU400, OCU410, OCU200, and COVAXIN. The firm's modifier gene therapy platform is engaged in addressing retinal diseases, including retinitis pigmentosa, leber congenital amaurosis, and dry age-related macular degeneration. The company was founded by Shankar Musunuri and Uday B. Kompella in 2013 and is headquartered in Malvern, PA.
Related stocks
OCGN I thinkOCGN completing a H&Swhith a neckline abaut a 1,
a brekkout of this level would complete the pattern a could
project to Tp of this pattern otherwise the failure could give new low
Ocugen Inc Co.Nasdaq Woow look at that harmonic shap target price real 100% .
6.000 $ target price
Buy as much as you can .
Ocugen Inc Co.Nasdaq Stock starting it's motive wave and target price above 1.000 $
Buying zone formed.
Buy it as much as you can 🔥
Ocugen Inc Co.Nasdaq 0.6200 $ is the explosion and Resistance level .
Any breaking up Buy it with all your funds you have .
A huge volume will appear soon .
Ocugen Inc Co.Nasdaq Harmonic shap on Stock, target prices 4 $ / 6.27 $
Reach 90% as it did before , and after rocket rally to almost 18 $
Very soon positive news i expected.
Ocugen Inc. (OCGN) SL-$0,7311 TP-$0,6026Technical Analysis:
Bearish formation with compression
Bearish breakout gap
MACD crossovers on Daily and H4 charts
Momentum
Behavioral pattern
OCGN Longdaily, trendline break + retest, + Gap, + trendline break
hook reversal
Long 0.76
Stop 0.67
Target 1.1, 2.0
Risk management is much more important than a good entry point.
I am not a PRO trader.
In my trading plan, the Max Risk of each short term trade should be less than 1% of an accoun
Ocugen Inc Co.Nasdaq It seems , there will be a surge in volume next days , where price targets are so high .
Price targets seems to be between 48 $ - 56 $ , and could reach about 127 $
We expect a Rocket 🚀 news very soon.
Ocugen Inc Co.Nasdaq Double Bottom pattern formed
Target price = 1.3 - 1.38
Accumulation zone started couple of weeks before.
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of OCGN is 1.0350 USD — it has increased by 17.01% in the past 24 hours. Watch Ocugen, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Ocugen, Inc. stocks are traded under the ticker OCGN.
OCGN stock has fallen by −1.88% compared to the previous week, the month change is a 24.78% rise, over the last year Ocugen, Inc. has showed a −23.33% decrease.
We've gathered analysts' opinions on Ocugen, Inc. future price: according to them, OCGN price has a max estimate of 8.00 USD and a min estimate of 4.00 USD. Watch OCGN chart and read a more detailed Ocugen, Inc. stock forecast: see what analysts think of Ocugen, Inc. and suggest that you do with its stocks.
OCGN reached its all-time high on Dec 3, 2014 with the price of 778.2000 USD, and its all-time low was 0.1700 USD and was reached on Jun 1, 2020. View more price dynamics on OCGN chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
OCGN stock is 16.72% volatile and has beta coefficient of 1.51. Track Ocugen, Inc. stock price on the chart and check out the list of the most volatile stocks — is Ocugen, Inc. there?
Today Ocugen, Inc. has the market capitalization of 286.51 M, it has decreased by −9.17% over the last week.
Yes, you can track Ocugen, Inc. financials in yearly and quarterly reports right on TradingView.
Ocugen, Inc. is going to release the next earnings report on Aug 1, 2025. Keep track of upcoming events with our Earnings Calendar.
OCGN earnings for the last quarter are −0.05 USD per share, whereas the estimation was −0.06 USD resulting in a 13.04% surprise. The estimated earnings for the next quarter are −0.06 USD per share. See more details about Ocugen, Inc. earnings.
Ocugen, Inc. revenue for the last quarter amounts to 1.48 M USD, despite the estimated figure of 0.00 USD. In the next quarter, revenue is expected to reach 466.67 K USD.
OCGN net income for the last quarter is −15.35 M USD, while the quarter before that showed −13.88 M USD of net income which accounts for −10.59% change. Track more Ocugen, Inc. financial stats to get the full picture.
No, OCGN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jun 25, 2025, the company has 95 employees. See our rating of the largest employees — is Ocugen, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Ocugen, Inc. EBITDA is −54.34 M USD, and current EBITDA margin is −1.30 K%. See more stats in Ocugen, Inc. financial statements.
Like other stocks, OCGN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Ocugen, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Ocugen, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Ocugen, Inc. stock shows the neutral signal. See more of Ocugen, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.